Related Experiment Videos
Detectable serum IgE levels in Graves' ophthalmopathy
I Molnár1, S Horváth, C Balázs
13rd Department of Internal Medicine, Kenézy County Teaching Hospital, Debrecen, Hungary.
European Journal of Medical Research
|September 20, 1996
Summary
Elevated immunoglobulin E (IgE) levels are linked to Graves' ophthalmopathy, an autoimmune eye disease. This study suggests IgE may contribute to eye inflammation, proposing antihistamines as a potential treatment.
Area of Science:
- Immunology
- Endocrinology
- Ophthalmology
Background:
- Graves' ophthalmopathy is an autoimmune disorder affecting the eyes, characterized by inflammation.
- Immunoglobulin E (IgE) is implicated in allergic reactions and normal immune responses.
- Previous studies suggest IgE accumulation around eye muscles in Graves' ophthalmopathy.
Purpose of the Study:
- To investigate the role of total IgE levels in Graves' disease and its associated ophthalmopathy.
- To determine if IgE contributes to the autoimmune or local inflammatory processes in the eyes.
Main Methods:
- Measured total IgE levels in 56 Graves' disease patients (47 with ophthalmopathy) and 42 healthy controls.
- Utilized the Enzymun-Test IgE, a two-step ELISA sandwich assay for IgE detection.
- Compared IgE levels between patient groups and controls, and assessed changes during treatment.
Main Results:
- Elevated circulating IgE levels were found in untreated hyperthyroid Graves' patients compared to controls.
- IgE levels were significantly higher in patients with active inflammatory eye signs.
- Treatment with anti-thyroid drugs and glucocorticoids reduced total IgE levels in Graves' patients.
Conclusions:
- The findings suggest that IgE plays a role in the inflammatory eye manifestations of Graves' ophthalmopathy.
- Antihistamines are proposed as a potential therapeutic option for managing the eye inflammation in Graves' ophthalmopathy.